Literature DB >> 24552479

Classics in chemical neuroscience: diazepam (valium).

Nicholas E Calcaterra1, James C Barrow.   

Abstract

Diazepam (Valium) is among the most successful drugs from the onset of the psychopharmacological revolution that began during the 1950s. Efficacious in treating a wide-spectrum of CNS disorders, including anxiety and epilepsy, it set the standard for pharmacotherapy in terms of potency, onset of action, and safety. In this Review, the legacy of diazepam to chemical neuroscience will be considered along with its synthesis, pharmacology, drug metabolism, adverse events and dependence, clinical use, and regulatory issues.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24552479      PMCID: PMC3990949          DOI: 10.1021/cn5000056

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  73 in total

1.  Pharmacophore/receptor models for GABA(A)/BzR subtypes (alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligand-mapping approach.

Authors:  Q Huang; X He; C Ma; R Liu; S Yu; C A Dayer; G R Wenger; R McKernan; J M Cook
Journal:  J Med Chem       Date:  2000-01-13       Impact factor: 7.446

2.  Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties.

Authors:  Travis T Wager; Xinjun Hou; Patrick R Verhoest; Anabella Villalobos
Journal:  ACS Chem Neurosci       Date:  2010-03-25       Impact factor: 4.418

3.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Olga Demler; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

4.  Transnational industrial power, the medical profession and the regulatory state: adverse drug reactions and the crisis over the safety of Halcion in the Netherlands and the UK.

Authors:  John Abraham
Journal:  Soc Sci Med       Date:  2002-11       Impact factor: 4.634

5.  The top prescription drugs of 2011 in the United States: antipsychotics and antidepressants once again lead CNS therapeutics.

Authors:  Craig W Lindsley
Journal:  ACS Chem Neurosci       Date:  2012-08-15       Impact factor: 4.418

6.  Trends in recommendations for the pharmacotherapy of anxiety disorders by an international expert panel, 1992-1997.

Authors:  E H Uhlenhuth; M B Balter; T A Ban; K Yang
Journal:  Eur Neuropsychopharmacol       Date:  1999-12       Impact factor: 4.600

Review 7.  New insights into the role of the GABA(A)-benzodiazepine receptor in psychiatric disorder.

Authors:  D J Nutt; A L Malizia
Journal:  Br J Psychiatry       Date:  2001-11       Impact factor: 9.319

Review 8.  Flunitrazepam: an evaluation of use, abuse and toxicity.

Authors:  H Druid; P Holmgren; J Ahlner
Journal:  Forensic Sci Int       Date:  2001-11-01       Impact factor: 2.395

Review 9.  Regulation of GABA(A) receptor subunit expression by pharmacological agents.

Authors:  Mikko Uusi-Oukari; Esa R Korpi
Journal:  Pharmacol Rev       Date:  2010-02-01       Impact factor: 25.468

Review 10.  Clinical significance of the cytochrome P450 2C19 genetic polymorphism.

Authors:  Zeruesenay Desta; Xiaojiong Zhao; Jae-Gook Shin; David A Flockhart
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

View more
  35 in total

1.  Diazepam reverses increased anxiety-like behavior, social behavior deficit, and dopamine dysregulation following withdrawal from acute amphetamine.

Authors:  Millie Rincón-Cortés; Kimberly G Gagnon; Hannah K Dollish; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2018-06-18       Impact factor: 7.853

2.  Photopotentiation of the GABAA receptor with caged diazepam.

Authors:  Lorenzo Sansalone; Joshua Bratsch-Prince; Sicheng Tang; Burjor Captain; David D Mott; Françisco M Raymo
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-01       Impact factor: 11.205

Review 3.  Amide Bond Bioisosteres: Strategies, Synthesis, and Successes.

Authors:  Shikha Kumari; Angelica V Carmona; Amit K Tiwari; Paul C Trippier
Journal:  J Med Chem       Date:  2020-08-04       Impact factor: 7.446

4.  Determination of minimal steady-state plasma level of diazepam causing seizure threshold elevation in rats.

Authors:  Ashish Dhir; Michael A Rogawski
Journal:  Epilepsia       Date:  2018-04-06       Impact factor: 5.864

5.  PSA-NCAM Colocalized with Cholecystokinin-Expressing Cells in the Hippocampus Is Involved in Mediating Antidepressant Efficacy.

Authors:  Jun Yamada; Chihiro Sato; Kohtarou Konno; Masahiko Watanabe; Shozo Jinno
Journal:  J Neurosci       Date:  2019-12-04       Impact factor: 6.167

6.  Effects of the psychoactive compounds in green tea on risky decision-making.

Authors:  Anna E Liley; Haleigh N Joyner; Daniel B K Gabriel; Nicholas W Simon
Journal:  Behav Pharmacol       Date:  2022-02-01       Impact factor: 2.293

Review 7.  A comprehensive review of remimazolam for sedation.

Authors:  Nazir Noor; Rhorer Legendre; Alexandra Cloutet; Ahish Chitneni; Giustino Varrassi; Alan D Kaye
Journal:  Health Psychol Res       Date:  2021-06-11

Review 8.  Tetrazoles via Multicomponent Reactions.

Authors:  Constantinos G Neochoritis; Ting Zhao; Alexander Dömling
Journal:  Chem Rev       Date:  2019-02-01       Impact factor: 60.622

Review 9.  The DARK Side of Total Synthesis: Strategies and Tactics in Psychoactive Drug Production.

Authors:  Schuyler A Chambers; Jenna M DeSousa; Eric D Huseman; Steven D Townsend
Journal:  ACS Chem Neurosci       Date:  2018-02-01       Impact factor: 4.418

10.  Behavioral Battery for Testing Candidate Analgesics in Mice. I. Validation with Positive and Negative Controls.

Authors:  C M Diester; E J Santos; M J Moerke; S S Negus
Journal:  J Pharmacol Exp Ther       Date:  2021-02-23       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.